OBJECTIVE: To assess the impact of admission to different hospital types on early and 1-year outcomes in patients with acute coronary syndrome (ACS). METHODS: Between 1997 and 2009, 31 010 ACS patients from 76 Swiss hospitals were enrolled in the AMIS Plus registry. Large tertiary institutions with continuous (24 hour/7 day) cardiac catheterisation facilities were classified as type A hospitals, and all others as type B. For 1-year outcomes, a subgroup of patients admitted after 2005 were studied. RESULTS: Eleven type A hospitals admitted 15987 (52%) patients and 65 type B hospitals 15023 (48%) patients. Patients admitted into B hospitals were older, more frequently female, diabetic, hypertensive, had more severe comorbidities and more frequent non-ST segment elevation (NSTE)-ACS/unstable angina (UA). STE-ACS patients admitted into B hospitals received more thrombolysis, but less percutaneous coronary intervention (PCI). Crude in-hospital mortality and major adverse cardiac events (MACE) were higher in patients from B hospitals. Crude 1-year mortality of 3747 ACS patients followed up was higher in patients admitted into B hospitals, but no differences were found for MACE. After adjustment for age, risk factors, type of ACS and comorbidities, hospital type was not an independent predictor of in-hospital mortality, in-hospital MACE, 1-year MACE or mortality. Admission indicated a crude outcome in favour of hospitalisation during duty-hours while 1-year outcome could not document a significant effect. CONCLUSION: ACS patients admitted to smaller regional Swiss hospitals were older, had more severe comorbidities, more NSTE-ACS and received less intensive treatment compared with the patients initially admitted to large tertiary institutions. However, hospital type was not an independent predictor of early and mid-term outcomes in these patients. Furthermore, our data suggest that Swiss hospitals have been functioning as an efficient network for the past 12 years.
OBJECTIVE: To assess the impact of admission to different hospital types on early and 1-year outcomes in patients with acute coronary syndrome (ACS). METHODS: Between 1997 and 2009, 31 010 ACS patients from 76 Swiss hospitals were enrolled in the AMIS Plus registry. Large tertiary institutions with continuous (24 hour/7 day) cardiac catheterisation facilities were classified as type A hospitals, and all others as type B. For 1-year outcomes, a subgroup of patients admitted after 2005 were studied. RESULTS: Eleven type A hospitals admitted 15987 (52%) patients and 65 type B hospitals 15023 (48%) patients. Patients admitted into B hospitals were older, more frequently female, diabetic, hypertensive, had more severe comorbidities and more frequent non-ST segment elevation (NSTE)-ACS/unstable angina (UA). STE-ACS patients admitted into B hospitals received more thrombolysis, but less percutaneous coronary intervention (PCI). Crude in-hospital mortality and major adverse cardiac events (MACE) were higher in patients from B hospitals. Crude 1-year mortality of 3747 ACS patients followed up was higher in patients admitted into B hospitals, but no differences were found for MACE. After adjustment for age, risk factors, type of ACS and comorbidities, hospital type was not an independent predictor of in-hospital mortality, in-hospital MACE, 1-year MACE or mortality. Admission indicated a crude outcome in favour of hospitalisation during duty-hours while 1-year outcome could not document a significant effect. CONCLUSION: ACS patients admitted to smaller regional Swiss hospitals were older, had more severe comorbidities, more NSTE-ACS and received less intensive treatment compared with the patients initially admitted to large tertiary institutions. However, hospital type was not an independent predictor of early and mid-term outcomes in these patients. Furthermore, our data suggest that Swiss hospitals have been functioning as an efficient network for the past 12 years.
Authors: Milosz Jaguszewski; Jelena-R Ghadri; Johanna Diekmann; Roxana D Bataiosu; Jens P Hellermann; Annahita Sarcon; Asim Siddique; Lukas Baumann; Barbara E Stähli; Thomas F Lüscher; Willibald Maier; Christian Templin Journal: Clin Res Cardiol Date: 2014-08-21 Impact factor: 5.460
Authors: Andreas W Schoenenberger; Nadja Urbanek; Stefan Toggweiler; Andreas E Stuck; Thérèse J Resink; Paul Erne Journal: World J Cardiol Date: 2013-03-26
Authors: Dragana Radovanovic; Bramajee K Nallamothu; Burkhardt Seifert; Osmund Bertel; Franz Eberli; Philip Urban; Giovanni Pedrazzini; Hans Rickli; Jean-Christophe Stauffer; Stephan Windecker; Paul Erne Journal: Eur Heart J Acute Cardiovasc Care Date: 2012-09
Authors: David Carballo; Cécile Delhumeau; Sebastian Carballo; Caroline Bähler; Dragona Radovanovic; Bernard Hirschel; Olivier Clerc; Enos Bernasconi; Dominique Fasel; Patrick Schmid; Alexia Cusini; Jan Fehr; Paul Erne; Pierre-Fréderic Keller; Bruno Ledergerber; Alexandra Calmy Journal: AIDS Res Ther Date: 2015-02-22 Impact factor: 2.250
Authors: Reto Auer; Baris Gencer; Lorenz Räber; Roland Klingenberg; Sebastian Carballo; David Carballo; David Nanchen; Jacques Cornuz; John-Paul Vader; Pierre Vogt; Peter Jüni; Christian M Matter; Stephan Windecker; Thomas Felix Lüscher; François Mach; Nicolas Rodondi Journal: PLoS One Date: 2014-03-27 Impact factor: 3.240